why choose us

First received: January 4, 2023

Clinical Trial: Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: SARS-CoV-2 Infection
Hematologic Malignancy

Study Type: Observational


Official Title: Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors and Discovery of Potential Drug Targets

Brief Summary: The goal of this observational study is to compare the immune function and infection mechanism of patients with hematologic tumors and those people without underlying diseases after infection with SARS-CoV-2. Clinical characteristics, treatment options and responses will be collected. Peripheral blood will be collected from patients with hematologic tumors infected with SARS-CoV-2 and those people without underlying diseases infected with SARS-CoV-2.

Read more